Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

The British Association for Psychopharmacology developed an evidence-based consensus guideline on the management of catatonia. A group of international experts from a wide range of disciplines was assembled. Evidence was gathered from existing systematic reviews and the primary literature. Recommendations were made on the basis of this evidence and were graded in terms of their strength. The guideline initially covers the diagnosis, aetiology, clinical features and descriptive epidemiology of catatonia. Clinical assessments, including history, physical examination and investigations are then considered. Treatment with benzodiazepines, electroconvulsive therapy and other pharmacological and neuromodulatory…

• SM
  Stanley Medical Research Institute
• NA
  National Alliance for Research on Schizophrenia and Depression
• WT
  Wellcome Trust

  Award: 220659/Z/20/Z
• RC
  Royal College of Physicians of Edinburgh
• VA
  VGH and UBC Hospital Foundation
• MS
  Michael Smith Health Research BC
• NI
  National Institute for Health and Care Research
• BM
  British Medical Association
• UC
  University College London
• DF
  Deutsche Forschungsgemeinschaft

  Awards: HI 1928/6-1, DFG HI 1928/5-1
• NI
  National Institutes of Health

  Awards: K23AG072383, MH070560
• H2
  Horizon 2020 Framework Programme
• OO
  Office of Rural Health
• CI
  Canadian Institutes of Health Research
• MR
  Medical Research Council
• UB
  UCLH Biomedical Research Centre
• NI
  National Institute on Aging

  Award: K23AG072383
• NI
  National Institute of Mental Health
• JP
  Janssen Pharmaceuticals
• WE
  Wisconsin Economic Development Corporation